Neovasc Inc. | Cash Flow

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
6,750.30
19,061.10
34,198.30
114,599.00
29,735.80
140,039.60
Depreciation, Depletion & Amortization
271.70
375.80
644.40
1,001.30
693.80
497.90
Other Funds
-
-
-
-
84,792.50
108,538.30
Funds from Operations
4,515.20
9,022.50
28,279.50
49,508.50
34,457.20
31,003.40
Changes in Working Capital
167.90
97.20
1,050.60
3,215.70
145,465.10
1,458
Net Operating Cash Flow
4,683.10
8,925.30
27,228.90
52,724.20
179,922.30
29,545.40
Capital Expenditures
1,041.20
1,249.00
2,741.90
869.40
656.40
Sale of Fixed Assets & Businesses
-
-
-
89,752.50
-
Purchase/Sale of Investments
-
12,000.00
11,927.00
595.90
-
Net Investing Cash Flow
696.30
13,249.00
9,185.10
88,287.20
656.40
Issuance/Reduction of Debt, Net
40.00
41.40
210.30
-
-
Net Financing Cash Flow
2,921.80
24,795.90
90,586.10
9,446.50
85,121.80
Net Change in Cash
2,457.60
2,621.50
63,754.60
50,252.20
97,934.80
Free Cash Flow
5,724.30
10,174.30
29,970.80
53,593.50
180,578.70
Other Sources
344.90
-
-
-
-
Change in Capital Stock
2,961.80
24,837.30
90,796.40
9,446.50
329.30
Exchange Rate Effect
-
-
8,787.70
5,242.60
2,477.90

About Neovasc

View Profile
Address
13562 Maycrest Way
Richmond British Columbia V6V 2J7
Canada
Employees -
Website http://www.neovasc.com
Updated 07/08/2019
Neovasc, Inc. engages in the development, manufacture, and marketing of medical devices for the cardiovascular marketplace. Its products includes Neovast Tiara and Neovasc Reducer. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada.